Amanote Research
Register
Sign In
Biosimilars
ESMO Open
- United Kingdom
doi 10.1136/esmoopen-2018-000321
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
January 1, 2018
Authors
Miguel Martin
Publisher
BMJ
Related search
Biosimilars 2.0
mAbs
Allergy
Immunology
Biosimilars in Medicine
Era's journal of medical research
Biosimilars: Approval and Acceptance?
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Building a Wall Against Biosimilars
Nature Biotechnology
Applied Microbiology
Biotechnology
Biomedical Engineering
Molecular Medicine
Bioengineering
Pcp34 - Biosimilars: What’s the Issue?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Will U.S. Payers Champion Biosimilars?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparative Immunogenicity Assessment of Biosimilars
Future Oncology
Medicine
Cancer Research
Oncology
Informationsportal Zu Biosimilars Im Internet
Best Practice Onkologie
Oncology
New Insulins, Biosimilars, and Insulin Therapy
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes